FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200475605> ?p ?o ?g. }

• W4200475605 endingPage "50" @default.
• W4200475605 startingPage "28" @default.
• W4200475605 abstract "Disorders of plasma lipids remain key risk factors for the development of atherosclerotic cardiovascular disease (ASCVD) in the Middle East and are estimated to increase more dramatically in the next decade than in any other global region except Africa. This statement is an update to the 2016 consensus clinical recommendations for the management of plasma lipid disorders in the Middle East, following the evaluation of newer cholesterol-lowering agents in randomised controlled cardiovascular outcome trials, as well as the publication of revised international guidelines.A multidisciplinary panel of regional experts was convened to update the consensus clinical recommendations for the management of plasma lipids in the Middle East. The recommendations constructed in 2016 were reviewed against emerging research since publication.Newly developed Middle East ASCVD risk categories were established using the multiple risk group categories from the recently updated international guidelines and the epidemiological evidence from the Gulf Region. These consensus recommendations support a more intensive reduction of LDL-C across cardiovascular risk categories. Alongside low-density lipoprotein cholesterol, we recommend non-high-density lipoprotein cholesterol as a primary treatment target. Lifestyle modifications remain the first-line treatment recommendation for all patients. The first-line pharmacological treatment in patients with dyslipidaemia is statin therapy, with a number of second-line agents available. The selection of a second lipid-lowering agent for combination therapy with statin should be based on the lipid-lowering target of the patient. Guidance is also provided on the management of underlying conditions and special populations; of particular pertinence in the region are familial hypercholesterolaemia, diabetes and metabolic dyslipidaemia. New therapies have emerged from research that found positive outcomes in reducing low-density lipoprotein cholesterol levels. The initial results of these newly researched drugs strongly indicate their inclusion as future therapies in dyslipidaemia management in the Middle East.These updated consensus clinical recommendations provide practicing clinicians with comprehensive, region-specific guidance to improve the detection and management of plasma lipid disorders in patients in the Middle East." @default.
• W4200475605 created "2021-12-31" @default.
• W4200475605 creator A5006206326 @default.
• W4200475605 creator A5010377982 @default.
• W4200475605 creator A5053351380 @default.
• W4200475605 creator A5062034086 @default.
• W4200475605 creator A5069357314 @default.
• W4200475605 creator A5076686773 @default.
• W4200475605 creator A5080623316 @default.
• W4200475605 creator A5082196683 @default.
• W4200475605 creator A5090057536 @default.
• W4200475605 date "2022-02-01" @default.
• W4200475605 modified "2023-10-06" @default.
• W4200475605 title "Consensus clinical recommendations for the management of plasma lipid disorders in the Middle East: 2021 update" @default.
• W4200475605 cites W120848922 @default.
• W4200475605 cites W1500847299 @default.
• W4200475605 cites W1520609538 @default.
• W4200475605 cites W1535628640 @default.
• W4200475605 cites W1595622977 @default.
• W4200475605 cites W1704010618 @default.
• W4200475605 cites W1709407542 @default.
• W4200475605 cites W1751598184 @default.
• W4200475605 cites W1856460279 @default.
• W4200475605 cites W1887831987 @default.
• W4200475605 cites W1936860915 @default.
• W4200475605 cites W1963557257 @default.
• W4200475605 cites W1964291837 @default.
• W4200475605 cites W1965675690 @default.
• W4200475605 cites W1966701899 @default.
• W4200475605 cites W1968949098 @default.
• W4200475605 cites W1972661406 @default.
• W4200475605 cites W1975018096 @default.
• W4200475605 cites W1978080134 @default.
• W4200475605 cites W1978239396 @default.
• W4200475605 cites W1988048988 @default.
• W4200475605 cites W1990092121 @default.
• W4200475605 cites W199262836 @default.
• W4200475605 cites W1993799331 @default.
• W4200475605 cites W1996592745 @default.
• W4200475605 cites W1996978408 @default.
• W4200475605 cites W2001314633 @default.
• W4200475605 cites W2004411922 @default.
• W4200475605 cites W2004673584 @default.
• W4200475605 cites W2008774662 @default.
• W4200475605 cites W2009383197 @default.
• W4200475605 cites W2010972693 @default.
• W4200475605 cites W2015410646 @default.
• W4200475605 cites W2016918979 @default.
• W4200475605 cites W2018888084 @default.
• W4200475605 cites W2020274264 @default.
• W4200475605 cites W2020915011 @default.
• W4200475605 cites W2023735564 @default.
• W4200475605 cites W2024710754 @default.
• W4200475605 cites W2029172015 @default.
• W4200475605 cites W2029505204 @default.
• W4200475605 cites W2031185570 @default.
• W4200475605 cites W2033892712 @default.
• W4200475605 cites W2035973195 @default.
• W4200475605 cites W2044947981 @default.
• W4200475605 cites W2047210903 @default.
• W4200475605 cites W2047766229 @default.
• W4200475605 cites W2050215249 @default.
• W4200475605 cites W2051352344 @default.
• W4200475605 cites W2056020568 @default.
• W4200475605 cites W2056288072 @default.
• W4200475605 cites W2058636061 @default.
• W4200475605 cites W2059934146 @default.
• W4200475605 cites W2067539811 @default.
• W4200475605 cites W2069014004 @default.
• W4200475605 cites W2071048602 @default.
• W4200475605 cites W2071418601 @default.
• W4200475605 cites W2080803671 @default.
• W4200475605 cites W2083031515 @default.
• W4200475605 cites W2086602774 @default.
• W4200475605 cites W2089358310 @default.
• W4200475605 cites W2090323433 @default.
• W4200475605 cites W2093598997 @default.
• W4200475605 cites W2094212464 @default.
• W4200475605 cites W2094333691 @default.
• W4200475605 cites W2096833639 @default.
• W4200475605 cites W2098890974 @default.
• W4200475605 cites W2099767767 @default.
• W4200475605 cites W2100800328 @default.
• W4200475605 cites W2102791045 @default.
• W4200475605 cites W2104191255 @default.
• W4200475605 cites W2104355263 @default.
• W4200475605 cites W2108451539 @default.
• W4200475605 cites W2110601215 @default.
• W4200475605 cites W2110619762 @default.
• W4200475605 cites W2111416524 @default.
• W4200475605 cites W2113760558 @default.
• W4200475605 cites W2115945685 @default.
• W4200475605 cites W2117730865 @default.
• W4200475605 cites W2118184073 @default.
• W4200475605 cites W2118667643 @default.
• W4200475605 cites W2121568629 @default.
• W4200475605 cites W2124565608 @default.
• W4200475605 cites W2124931944 @default.

• next